Condition: Familial Pancreatic Cancer · BRCA1 Mutation · BRCA2 Mutation · Sponsor: Associazione Italiana per lo Studio del Pancreas
IRFARPC is a multicenter national registry designed to study the diagnosis and predisposing factors of subjects with an inherited increased risk for pancreatic cancer.
This description comes directly from the study's public registry record.
Salvatore Paiella, MD, PhD · 00390458126009 · salvatore.paiella@univr.it
Silvia Carrara, MD · + 39 02 82247288 · silvia.carrara@humanitas.it
Always discuss trial participation with your own doctor first.
| Istituto Clinico Humanitas | Rozzano, Milan, Italy | Recruiting |
| Ospedale Pederzoli | Peschiera del Garda, Verona, Italy | Recruiting |
| San Raffele Vita Salute University Hospital | Milan, Italy | Recruiting |
| Chirurgia Generale e del Pancreas | Verona, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04095195